You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

MILRINONE LACTATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Milrinone Lactate, and when can generic versions of Milrinone Lactate launch?

Milrinone Lactate is a drug marketed by Baxter Hlthcare Corp, Caplin, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hikma Farmaceutica, Hospira, Intl Medicated, Meitheal, Mylan Institutional, Shandong, Eugia Pharma, Woodward, B Braun, Baxter Hlthcare, and West-ward Pharms Int. and is included in twenty-five NDAs.

The generic ingredient in MILRINONE LACTATE is milrinone lactate. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Milrinone Lactate

A generic version of MILRINONE LACTATE was approved as milrinone lactate by FRESENIUS KABI USA on May 28th, 2002.

  Try a Trial

Drug patent expirations by year for MILRINONE LACTATE
Drug Prices for MILRINONE LACTATE

See drug prices for MILRINONE LACTATE

Recent Clinical Trials for MILRINONE LACTATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Children's Medical CenterPhase 3
Ottawa Heart Institute Research CorporationPhase 4
University of PennsylvaniaN/A

See all MILRINONE LACTATE clinical trials

Pharmacology for MILRINONE LACTATE
Medical Subject Heading (MeSH) Categories for MILRINONE LACTATE

US Patents and Regulatory Information for MILRINONE LACTATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Farmaceutica MILRINONE LACTATE IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 090038-002 Jan 21, 2010 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
West-ward Pharms Int MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 078113-001 May 21, 2008 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
West-ward Pharms Int MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 078113-002 May 21, 2008 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Baxter Hlthcare Corp MILRINONE LACTATE milrinone lactate INJECTABLE;INJECTION 076427-001 Sep 21, 2004 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Woodward MILRINONE LACTATE IN DEXTROSE 5% milrinone lactate INJECTABLE;INJECTION 077151-002 Jul 20, 2005 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Gland Pharma Ltd MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 213585-002 Jul 16, 2020 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.